PACTR202304550587833招募中4 期
Comparison of bismuth quadruple therapy with Clarithromycin quadruple therapy in the treatment of Helicobacter pylori: a randomized controlled trial
Galpharma0 个研究点目标入组 200 人开始时间: 2023年3月29日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Age 18 to 60 years.
- •Patients with H. pylori infection documented by pathological evidence (gastric biopsy), by breath test or by H. pylori Antigen in stool and who have never received H. pylori eradication treatment.
- •Patients who gave informed consent for participation in our research.
排除标准
- •Patient has serious underlying diseases such as hepatic failure, renal failure , immunosuppression, malignancies, coronary artery disease, or severe psychiatric or neurological disorders.
- •The patient is a pregnant or lactating woman.
- •Patient has active gastrointestinal bleeding or a history of upper gastrointestinal surgery.
- •The patient is allergic to the drugs in the treatment.
研究者
相似试验
Unknown
4 期
Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori InfectionHelicobacter Pylori InfectionNCT01906879National Taiwan University Hospital1,620
已完成
2 期
bismuth- containing quadruple and high-dose dual therapy in eradication of Helicobacter pylori infectioEradication of Helicobacter pylori infection.?????????? ?????? ?? ????? ???? ?????? ?? ?? ?? ??? ??? ???? ???? ???? ?? ???B98.0IRCT20221016056190N1Shahid Beheshti University of Medical Sciences200
已完成
2 期
Comparing regimens ( Bismuth sub-citrate , Omeprazole , Amoxicillin , Clarithromycin , Tinidazole ) and ( Bismuth sub citrate , Omeprazole , Tetracycline , Metronidazole , Ofloxacin ) on the eradication rate of Helicobacter pylori infection in non responder dyspeptic patientsdyspepsia.DyspepsiaIRCT201103011155N11Vince chancellor for reaserch guilan univercity of medical sciences
进行中（未招募）
不适用
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysMedDRA version: 9.1Level: HLTClassification code 10019375Term: Helicobacter infectionsHelicobacter pylori infectionEUCTR2007-006280-78-IEAxcan Pharma Inc.400
已完成
3 期
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysGastric complaintsHelicobacter infection1001796610004018NL-OMON32065Axcan Pharma16